IRIDEX (IRIX)
(Delayed Data from NSDQ)
$2.13 USD
+0.01 (0.47%)
Updated Jul 16, 2024 03:59 PM ET
After-Market: $2.07 -0.06 (-2.82%) 6:20 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Brokerage Reports
IRIDEX Corporation [IRIX]
Reports for Purchase
Showing records 1 - 20 ( 110 total )
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
We are updating our Healthcare coverage to reflect a recent analyst departure and to drop
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
3Q23 Recap - G6 Noise Continues; Strategic Review Ongoing
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
1Q23 Recap - Compelling Valuation and Declining Losses
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
3Q22 Recap - Growth, Runway, and a Significant Discount
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
2Q22 Recap - Choppy Quarter, But Priced for Worse
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S